2022 Ljubljana, Slovenia

II-11 S. Y. Amy Cheung
Exposure-Response Analysis of Tovorafenib (DAY101) Relating Objective Response to Exposure, Patient- and Disease Characteristics
Wednesday 15:10-16:40